CCR5 and HIV-1 infection: Maraviroc, a CCR5 antagonist which interferes with HIV- envelope (Env) binding to CCR5 by allosteric modulation, showed promising results in preventing HIV-1 infection in humanized RAG-hu mice and macaques.